Century Next Financial Corp CTUY Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2013 at 12:46 AM

Century Next Financial Corp CTUY Company Overview

Stock Message Board http://investorshangout.com/search?q=CTUY&...mp;yt1=Go!

Century Next Financial Corp CTUY Current Price and Quotes
16.25
Previous Close
16.25
Open
N/A

Daily Range
N/A - N/A
52wk Range
16.25 - 12.40

Volume
0
Dividend
N/A

Average Vol (3m)
303
Yield
N/A

Century Next Financial Corp CTUY
Company Information
505 North Vienna St.
Ruston, LA 71270

Phone: 318-255-3733

Century Next Financial Corp CTUY
Century Next Financial Corp CTUY
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001493006
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 6035 - Federal savings institutions
Incorporated In: LA, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Benjamin L. Denny President, CEO
Mark A. Taylor CFO
Company Directors
Not Available
Service Providers
Auditor/Accountant
Heard, McElroy & Vestal, LLP
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Century Next Financial Corp CTUY
CTUY Security Details
Share Structure
Market Value1 $17,117,896 a/o Sep 03, 2013
Shares Outstanding 1,053,409 a/o Aug 09, 2013
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record 205 a/o Mar 26, 2013
Short Selling Data
Short Interest 2 (100%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Registrar and Transfer Co.

Century Next Financial Corp CTUY Recent News

Century Next Financial Corp CTUY Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 6,580 6,124 5,591 5,179
Cost of Revenue 632 776 993 1,293
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 4,745 4,237 3,525 3,219
Non-Recurring Items 101 190 25 -
Other 120 56 43 16
Operating Income - - - -
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 982 865 1,005 651
Interest Expense 25 25 14 5
Earnings Before Tax 957 840 991 646
Income Tax 301 206 335 182
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 656 634 656 464
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 656 634 656 464
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 656 634 656 464

CTUY Century Next Financial Corp Research DD Guide

CTUY Century Next Financial Corp Stock Message Board http://investorshangout.com/search?q=CTUY&...mp;yt0=Go!
CTUY Century Next Financial Corp Stock Quote http://www.otcmarkets.com/stock/CTUY/quote
CTUY Century Next Financial Corp Stock Chart http://www.otcmarkets.com/stock/CTUY/chart
CTUY Century Next Financial Corp Company Info http://www.otcmarkets.com/stock/CTUY/company-info
CTUY Century Next Financial Corp Recent News http://www.otcmarkets.com/stock/CTUY/news
CTUY Century Next Financial Corp Financials http://www.otcmarkets.com/stock/CTUY/financials
CTUY Century Next Financial Corp Filings and Disclosure http://www.otcmarkets.com/stock/CTUY/filings
CTUY Century Next Financial Corp Short Sales http://www.otcmarkets.com/stock/CTUY/short-sales
CTUY Century Next Financial Corp Insider Disclosure http://www.otcmarkets.com/stock/CTUY/insider-transactions
CTUY Century Next Financial Corp Research Reports http://www.otcmarkets.com/stock/CTUY/research
CTUY Century Next Financial Corp Summary http://finance.yahoo.com/q?s=CTUY
CTUY Century Next Financial Corp Historical Prices http://finance.yahoo.com/q/hp?s=CTUY+Historical+Prices
CTUY Century Next Financial Corp Interactive Chart http://finance.yahoo.com/echarts?s=CTUY
CTUY Century Next Financial Corp Basic Chart http://finance.yahoo.com/q/bc?s=CTUY+Basic+Chart
CTUY Century Next Financial Corp Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTUY+Basic+Tech.+Analysis
CTUY Century Next Financial Corp Headlines http://finance.yahoo.com/q/h?s=CTUY+Headlines
CTUY Century Next Financial Corp Press Releases http://finance.yahoo.com/q/p?s=CTUY+Press+Releases
CTUY Century Next Financial Corp Company Profile http://finance.yahoo.com/q/pr?s=CTUY+Profile
CTUY Century Next Financial Corp Key Statistics http://finance.yahoo.com/q/ks?s=CTUY+Key+Statistics
CTUY Century Next Financial Corp Industry http://finance.yahoo.com/q/in?s=CTUY+Industry
CTUY Century Next Financial Corp Major Holders http://finance.yahoo.com/q/mh?s=CTUY+Major+Holders
CTUY Century Next Financial Corp Insider Transactions http://finance.yahoo.com/q/it?s=CTUY+Insider+Transactions
CTUY Century Next Financial Corp Insider Roster http://finance.yahoo.com/q/ir?s=CTUY+Insider+Roster
CTUY Century Next Financial Corp Income Statement http://finance.yahoo.com/q/is?s=CTUY
CTUY Century Next Financial Corp Balance Sheet http://finance.yahoo.com/q/bs?s=CTUY
CTUY Century Next Financial Corp Cash Flow http://finance.yahoo.com/q/cf?s=CTUY+Cash+Flow&annual
CTUY Century Next Financial Corp Nasdaq http://www.nasdaq.com/symbol/CTUY
CTUY Century Next Financial Corp Market Watch http://www.marketwatch.com/investing/stock/CTUY
CTUY Century Next Financial Corp Bloomberg http://www.bloomberg.com/quote/CTUY:US
CTUY Century Next Financial Corp Morningstar http://quotes.morningstar.com/stock/s?t=CTUY
CTUY Century Next Financial Corp Bussinessweek http://investing.businessweek.com/research/st...icker=CTUY
CTUY Century Next Financial Corp Barchart http://www.barchart.com/quotes/stocks/CTUY
CTUY Century Next Financial Corp OTC Short Report http://otcshortreport.com/index.php?index=CTUY
CTUY Century Next Financial Corp Investopedia http://www.investopedia.com/markets/stocks/CTUY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...